A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.574
https://www.valueinhealthjournal.com/article/S1098-3015(15)02650-9/fulltext
Title :
A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02650-9&doi=10.1016/j.jval.2015.09.574
First page :
A424
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
494